DIACYLGLYCEROL KINASE INHIBITOR II
DIACYLGLYCEROL KINASE INHIBITOR II Basic information
- Product Name:
- DIACYLGLYCEROL KINASE INHIBITOR II
- Synonyms:
-
- DIACYLGLYCEROL KINASE INHIBITOR I (R59 949)
- DIACYLGLYCEROL KINASE INHIBITOR II
- R59949, 3-[2-[4-(bis(4-Fluorophenyl)methylene)-1-piperidinyl]ethyl]-2,3-dihydro-2-thioxo-4(1H)-quinazolinone
- 3-[2-[4-Bis(4-fluorophenyl)methylenepiperidino]ethyl]-2,3-dihydro-2-thioxoquinazolin-4(1H)-one
- 3-[2-[4-(bis(4-Fluorophenyl)Methylene)-1-piperidinyl]ethyl]-2,3-dihydro-2-thioxo-4(1H)-quinazolinone, R59949
- DAG Kinase Inhibitor II
- DAG Kinase Inhibitor
- 3-[2-(4-[BIS(4-FLUOROPHENYL)-METHYLENE)-1-PIPERIDINYL)ETHYL]-2,3-DIHYDRO-2-THIOXO-4[1H]-QUINAZOLINONE
- CAS:
- 120166-69-0
- MF:
- C28H25F2N3OS
- MW:
- 489.58
- Product Categories:
-
- quinazolinone
- Mol File:
- 120166-69-0.mol
DIACYLGLYCEROL KINASE INHIBITOR II Chemical Properties
- Melting point:
- 228-230 °C
- Boiling point:
- 637.1±65.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- solubility
- 0.1 M HCl: slightly soluble
- form
- solid
- pka
- 11.24±0.20(Predicted)
- color
- pale yellow
- biological source
- synthetic (organic)
MSDS
- Language:English Provider:SigmaAldrich
DIACYLGLYCEROL KINASE INHIBITOR II Usage And Synthesis
Description
R-59-949 is an inhibitor of diacylglycerol kinase α (DGK-α) with an IC50 value of 300 nM in isolated platelet plasma membranes using exogenous diacylglycerol as a substrate. DGK-α inhibition with R-59-949 increases diacylglycerol-dependent PKC activity, serotonin secretion, and aggregation of thrombin-stimulated platelets. R-59-949 inhibits DGK-α activity induced by platelet-derived growth factor (PDGF) in intact vascular smooth muscle cells (VSMCs). It inhibits high K+- and glucose-induced insulin secretion in MIN6 pancreatic β-cells in a dose-dependent manner. In vivo, administration of R-59-949 prevents retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Uses
Diacylglycerol Kinase Inhibitor II has been used to determine tumor-induced inhibition with genetically modified cytotoxic T cells expressing chimeric antigen receptors (CAR). It has also been used to induce pAkt and PKR-like extracellular signal-regulated kinase (pErk) signals in T-cell acute lymphoblastic leukemia (T-ALL) cells.
Definition
ChEBI: 3-[2-[4-[bis(4-fluorophenyl)methylidene]-1-piperidinyl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one is a diarylmethane.
Biochem/physiol Actions
Diacylglycerol kinase inhibitor. Inhibits formation of [38P]1-Oleoyl-2-acetylglyceryl-3-phosphoric acid (OAPA) in red blood cell membranes: IC50 = 3.3 μM.
DIACYLGLYCEROL KINASE INHIBITOR IISupplier
- Tel
- 020-39119399 18927568969
- isunpharm@qq.com
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 15076683720
- klq@cw-bio.com
- Tel
- 17754423994 17754423994
- 2853530910@QQ.com
DIACYLGLYCEROL KINASE INHIBITOR II(120166-69-0)Related Product Information
- 4-Fluorostyrene
- N-(2-Aminoethyl)piperidine
- 4-[(4-Fluorophenyl)methylene]piperidine
- 4,4'-Difluorodiphenylmethane
- 1-Fluoro-4-(1-methylethenyl)benzene
- 1-BENZOYL-2-THIOUREA
- 4-(DIPHENYLMETHYLENE)PIPERIDINE
- 1-Methyl-4-methylene-piperidine
- 3-ETHYL-2-THIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE
- 2-AMINO-N,N-DIMETHYL-BENZAMIDE
- N-ETHYL-2-PIPERIDIN-1-YLETHANAMINE
- N-BENZYL-N-METHYLTHIOUREA
- METHYL-(2-PIPERIDIN-1-YL-ETHYL)-AMINE
- N,N-DIETHYLTHIOUREA
- 1-(2-PIPERIDINOETHYL)-2-THIOUREA
- 1,1-BIS(4-FLUOROPHENYL)-1-BUTENE
- DIACYLGLYCEROL KINASE INHIBITOR II
- N-METHYL-N-(2-METHYLAMINO-ETHYL)-BENZAMIDE